Controversies in the Management of Endometrial Cancer

Table 1

Carcinoma of the corpus uteri (FIGO 2008).

Stage I*	Tumour confined to the corpus uteri.
IA*	No or less than half myometrial invasion.
IB*	More than half myometrial invasion.
Stage II*	Tumour invades cervical stroma, but does not extend beyond the uterus.**
Stage III*	Local and/or regional spread of the tumour.
IIIA*	Tumor invades the serosa of the corpus uteri and/or adnexae^#.
IIIB*	Vaginal and/or parametrial involvement^#.
IIIC*	Metastases to pelvic and/or para-aortic lymph nodes^#.
IIIC1*	(i) Positive pelvic nodes
IIIC2*	(ii) Positive paraortic lymphnodes with or without positive pelvic lymphnodes.
Stage IV*	Tumor invades bladder and/or bowel mucosa, and/or distant metastases.
IVA*	Tumor invasion of bladder and/or bowel mucosa.
IVB*	Distant metastases, including intra-abdominal metastases and/or inguinal lymph nodes.

∗Either G1, G2, or G3.
∗∗Endocervical glandular involvement only should be considered as Stage I and no more as Stage II.
^#Positive cytology has to be reported separately without changing the stage.